The Todd Huff Radio Show

The Trump administration has engaged in ongoing negotiations with China to resolve the trade conflict that escalated after both nations imposed a series of retaliatory tariffs. These discussions aim to de-escalate tensions and address longstanding concerns over trade imbalances, intellectual property rights, and market access, with the goal of reaching a more equitable and stable economic relationship between the two countries. President Trump is preparing to sign a new executive order focused on reducing the cost of prescription drugs in the United States. The measure is part of a broader initiative aimed at increasing price transparency, promoting competition within the pharmaceutical industry, and potentially tying drug prices in the U.S. to lower international rates. Supporters of the order argue it could provide much-needed relief for patients burdened by high medication costs, while critics caution about potential impacts on innovation and drug availability. Freedom Marketplace: https://freedommarketpla